论文部分内容阅读
Montelukast Sodium(Singulair○R)是一种白三烯受体拮抗剂 ,由默克公司申请上市 ,用于成人和 12个月以上小儿哮喘的长期治疗和预防。本品还被批准用于缓解成人和两岁以上儿童的季节性变应性鼻炎 (SAR)症状。结构式 :分子式 :C35H35Cl NNa O3SCAS:15 176 7- 0 2 - 1药理作用
Montelukast Sodium (Singulair ○ R), a leukotriene receptor antagonist, is marketed by Merck for long-term treatment and prevention of asthma in adults and children over 12 months old. This product is also approved for the relief of seasonal allergic rhinitis (SAR) in adults and children over the age of two. Structure: Molecular formula: C35H35Cl NNa O3SCAS: 15 176 7- 0 2 - 1 Pharmacological effect